Skip to content

Clinical Study of Air Moxibustion Combined with Intradermal Needle Intervention on Embolism Syndrome after TACE Based on Theory of Supporting Spleen and Restricting Liver

Clinical Study of Air Moxibustion Combined with Intradermal Needle Intervention on Embolism Syndrome after TACE Based on Theory of Supporting Spleen and Restricting Liver

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000253
Enrollment
Unknown
Registered
2024-08-16
Start date
2021-06-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cancer

Interventions

Control group:conventional care
Intradermal needle group:conventional care and intradermal needle
Air moxibustion group:conventional care and air moxibustion
Combined group:the intradermal needle was mixed with air moxibustion

Sponsors

The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 89 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosis of primary liver cancer after clinical and pathological examination according to the Code for Diagnosis and Treatment of Primary Liver Cancer (2019 Edition)[12]. (2) The Child-Pugh score was "A" or "B" (3) Meet TACE indications. (4) Patients with good compliance and clear consciousness who could cooperate with the treatment. (5) Before the intervention, the body temperature of the patients was not higher than the standard value.

Exclusion criteria

Exclusion criteria: (1) Participants in other research projects simultaneously. (2) Patients with redness, rash, damage, or scarring on the skin at the acupoints. (3) Patients with allergic constitution or allergy to metal articles, moxa, etc. (4) Patients with primary liver cancer with metastasis to other organs.

Design outcomes

Primary

MeasureTime frame
body temperature;

Secondary

MeasureTime frame
Index nausea and vomiting andretching;Gastric capacity;liver function indexes;Use of analgesics;Visual analogue scale;Use of antiemetic agents;

Countries

china

Contacts

Public ContactXuemei Bian

The First Affiliated Hospital of Zhejiang Chinese Medical University

bxm7013@126.com+86 135 8849 2353

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026